A new inactive form of p38α protein discovered

p38α protein, a key enzyme in the regulation of various cellular functions, plays a crucial role in some diseases, including cancer, chronic inflammation, and neurodegenerative conditions. Since the discovery of p38α, various ...

AI generates proteins with exceptional binding strengths

A new study in Nature reports an AI-driven advance in biotechnology with implications for drug development, disease detection, and environmental monitoring. Scientists at the Institute for Protein Design at the University ...

Catalyst makes drugs inside the body to minimize side effects

A highly active catalyst capable of synthesizing drug molecules within the body has been developed by RIKEN chemists. In mice, an anticancer drug assembled near tumors using the injected catalyst suppressed tumor growth.

A catalyst for electronically controlled C–H functionalization

The Chirik Group at the Princeton Department of Chemistry is chipping away at one of the great challenges of metal-catalyzed C–H functionalization with a new method that uses a cobalt catalyst to differentiate between bonds ...

Polyoxometalates show promise as drug transporters into the cell

A research team from the University of Vienna, in collaboration with the Constructor University in Bremen, showed that polyoxometalates (POMs) can transport biologically relevant cargo through biological membranes. The study ...

page 13 from 40